KYTX
Kyverna Therapeutics, Inc.
6.80$
-2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +24.2% | -100.0% | – | – | |
| – | +79.4% | +62.4% | +25.0% | -15.7% | |
| – | +24.2% | -124.3% | – | – | |
| – | +9.9% | +69.8% | +133.3% | +18.9% | |
| – | +30.2% | +55.9% | +141.4% | +19.8% | |
| – | +13.8% | +66.7% | +131.4% | +20.9% | |
| – | – | – | – | – | |
| – | +2,066.7% | +187.7% | -24.1% | +244.4% | |
| – | – | – | – | – | |
| – | +5,500.0% | +135.7% | -96,673.5% | – | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.